» Articles » PMID: 24736450

The Early Activation of Toll-like Receptor (TLR)-3 Initiates Kidney Injury After Ischemia and Reperfusion

Overview
Journal PLoS One
Date 2014 Apr 17
PMID 24736450
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Acute kidney injury (AKI) is one of the most important complications in hospitalized patients and its pathomechanisms are not completely elucidated. We hypothesize that signaling via toll-like receptor (TLR)-3, a receptor that is activated upon binding of double-stranded nucleotides, might play a crucial role in the pathogenesis of AKI following ischemia and reperfusion (IR). Male adult C57Bl6 wild-type (wt) mice and TLR-3 knock-out (-/-) mice were subjected to 30 minutes bilateral selective clamping of the renal artery followed by reperfusion for 30 min 2.5h and 23.5 hours or subjected to sham procedures. TLR-3 down-stream signaling was activated already within 3 h of ischemia and reperfusion in post-ischemic kidneys of wt mice lead to impaired blood perfusion followed by a strong pro-inflammatory response with significant neutrophil invasion. In contrast, this effect was absent in TLR-3-/- mice. Moreover, the quick TLR-3 activation resulted in kidney damage that was histomorphologically associated with significantly increased apoptosis and necrosis rates in renal tubules of wt mice. This finding was confirmed by increased kidney injury marker NGAL in wt mice and a better preserved renal perfusion after IR in TLR-3-/- mice than wt mice. Overall, the absence of TLR-3 is associated with lower cumulative kidney damage and maintained renal blood perfusion within the first 24 hours of reperfusion. Thus, we conclude that TLR-3 seems to participate in the pathogenesis of early acute kidney injury.

Citing Articles

Human pulmonary microvascular endothelial cells respond to DAMPs from injured renal tubular cells.

DeWolf S, Hawkes A, Kurian S, Gorial D, Hepokoski M, Almeida S Pulm Circ. 2024; 14(3):e12379.

PMID: 38962184 PMC: 11220341. DOI: 10.1002/pul2.12379.


Protective effects of pioglitazone in renal ischemia-reperfusion injury (RIRI): focus on oxidative stress and inflammation.

Golmohammadi M, Sadeghi Ivraghi M, Hasan E, Huldani H, Zamanian M, Rouzbahani S Clin Exp Nephrol. 2024; 28(10):955-968.

PMID: 38935212 DOI: 10.1007/s10157-024-02525-3.


Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions.

Otunla A, Shanmugarajah K, Davies A, Shalhoub J Front Pharmacol. 2024; 15:1355674.

PMID: 38464721 PMC: 10924325. DOI: 10.3389/fphar.2024.1355674.


Prunetin in a GPR30-dependent manner mitigates renal ischemia/reperfusion injury in rats via interrupting indoxyl sulfate/TLR4/TRIF, RIPK1/RIPK3/MLKL, and RIPK3/PGAM5/DRP-1 crosstalk.

Hamed A, El-Abhar H, Abdallah D, Ahmed K, AbulFadl Y Saudi Pharm J. 2023; 31(11):101818.

PMID: 37868646 PMC: 10587762. DOI: 10.1016/j.jsps.2023.101818.


Simultaneous C5 and CD14 inhibition limits inflammation and organ dysfunction in pig polytrauma.

Lupu L, Horst K, Greven J, Mert U, Ludviksen J, Pettersen K Front Immunol. 2022; 13:952267.

PMID: 36059503 PMC: 9433645. DOI: 10.3389/fimmu.2022.952267.


References
1.
Paulus P, Stanley E, Schafer R, Abraham D, Aharinejad S . Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res. 2006; 66(8):4349-56. DOI: 10.1158/0008-5472.CAN-05-3523. View

2.
Shirali A, Goldstein D . Tracking the toll of kidney disease. J Am Soc Nephrol. 2008; 19(8):1444-50. DOI: 10.1681/ASN.2008010123. View

3.
Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y . Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol. 2002; 169(4):2026-33. DOI: 10.4049/jimmunol.169.4.2026. View

4.
Gluba A, Banach M, Hannam S, Mikhailidis D, Sakowicz A, Rysz J . The role of Toll-like receptors in renal diseases. Nat Rev Nephrol. 2010; 6(4):224-35. DOI: 10.1038/nrneph.2010.16. View

5.
Vanhoutte F, Paget C, Breuilh L, Fontaine J, Vendeville C, Goriely S . Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells. Immunol Lett. 2008; 116(1):86-94. DOI: 10.1016/j.imlet.2007.11.014. View